WallStSmart
HRMY

Harmony Biosciences Holdings

NASDAQ: HRMY · HEALTHCARE · BIOTECHNOLOGY

$31.05
-0.35% today

Updated 2026-04-29

Market cap
$1.80B
P/E ratio
11.46
P/S ratio
2.07x
EPS (TTM)
$2.71
Dividend yield
52W range
$26 – $41
Volume
1.1M

Harmony Biosciences Holdings (HRMY) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20182019202020212022202320242025
Revenue$0.00$6.00M$159.74M$305.44M$437.86M$582.02M$714.73M$868.45M
Revenue growth (YoY)+2564.6%+91.2%+43.4%+32.9%+22.8%+21.5%
Cost of revenue$184000.00$1.58M$27.74M$55.52M$83.48M$121.24M$156.81M$198.34M
Gross profit$-184000.00$4.42M$132.00M$249.92M$354.37M$460.79M$557.92M$670.11M
Gross margin73.7%82.6%81.8%80.9%79.2%78.1%77.2%
R&D$12.37M$69.59M$19.45M$30.37M$70.89M$76.06M$145.82M$189.59M
SG&A$12.21M$36.41M$39.75M$63.91M$84.02M$95.29M$110.35M$152.54M
Operating income$-41.44M$-145.90M$16.99M$87.53M$120.19M$192.03M$190.83M$208.47M
Operating margin-2433.8%10.6%28.7%27.4%33.0%26.7%24.0%
EBITDA$-41.26M$-142.69M$1.51M$80.46M$146.87M$221.51M$233.41M$255.05M
EBITDA margin-2380.2%0.9%26.3%33.5%38.1%32.7%29.4%
EBIT$-41.44M$-145.90M$-8.72M$61.62M$123.48M$197.15M$209.30M$229.71M
Interest expense$0.00$6.07M$28.22M$24.19M$18.80M$23.76M$17.50M$14.65M
Income tax$1.54M$6.07M$14.91M$2.83M$-76.78M$44.54M$46.31M
Effective tax rate-4.0%-4.2%-67.7%7.6%-73.3%25.7%24.1%0.0%
Net income$-39.90M$-151.98M$-36.94M$34.60M$181.47M$128.85M$145.49M$158.69M
Net income growth (YoY)-280.9%+75.7%+193.6%+424.5%-29.0%+12.9%+9.1%
Profit margin-2535.1%-23.1%11.3%41.4%22.1%20.4%18.3%